These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 16282513

  • 21. [Pharmacogenetic testing: soon before every prescription?].
    Buclin T, Colombo S, Biollaz J.
    Rev Med Suisse; 2008 Jul 16; 4(165):1666-70. PubMed ID: 18767293
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS, Kim D.
    Arch Pharm Res; 2011 Nov 16; 34(11):1799-816. PubMed ID: 22139682
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Genetic variability in cytochrome P450 3A5 and in vivo cytochrome P450 3A activity: some answers but still questions.
    Wilkinson GR.
    Clin Pharmacol Ther; 2004 Aug 16; 76(2):99-103. PubMed ID: 15289786
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Role of cytochrome P450 enzymes in pharmaceutical preparations].
    Baede van Dijk PA, de Graeff PA, Lekkerkerker JF.
    Ned Tijdschr Geneeskd; 1999 Dec 25; 143(52):2607-11. PubMed ID: 10633805
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacogenomic protocols in CNS disorders and dementia.
    Cacabelos R.
    Neurodegener Dis; 2010 Dec 25; 7(1-3):167-9. PubMed ID: 20197699
    [Abstract] [Full Text] [Related]

  • 34. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes.
    Touw DJ.
    Drug Metabol Drug Interact; 1997 Dec 25; 14(2):55-82. PubMed ID: 9893738
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Human biodiversity and its effects on the pharmacological variability: CYP2D6 and NAT2 enzymes in Amerind populations of Panama, Colombia and Costa Rica].
    Jorge LF, Arias TD.
    Rev Med Panama; 1995 Sep 25; 20(3):98-107. PubMed ID: 8668827
    [Abstract] [Full Text] [Related]

  • 37. [Adverse effects and drug interactions].
    Perlík F.
    Cas Lek Cesk; 2004 Sep 25; 143(2):110-3. PubMed ID: 15077574
    [Abstract] [Full Text] [Related]

  • 38. Effect of sinomenine on human cytochrome P450 activity.
    Yao YM, Cao W, Cao YJ, Cheng ZN, Ou-Yang DS, Liu ZQ, Zhou HH.
    Clin Chim Acta; 2007 Apr 25; 379(1-2):113-8. PubMed ID: 17292874
    [Abstract] [Full Text] [Related]

  • 39. Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.
    Yoo HD, Lee YB.
    Arch Pharm Res; 2011 Nov 25; 34(11):1817-28. PubMed ID: 22139683
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.